Tags

Type your tag names separated by a space and hit enter

COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
Hum Vaccin Immunother. 2022 12 31; 18(1):1-6.HV

Abstract

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Links

Publisher Full Text
ncbi.nlm.nih.gov
tandfonline.com
PMC Free PDF

Authors+Show Affiliations

Carcelen AC
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Prosperi C
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Mutembo S
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Laboratory Science, Macha Research Trust, Choma, Zambia.
Chongwe G
Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.
Mwansa FD
Ministry of the Health, Government of the Republic of Zambia, Lusaka, Zambia.
Ndubani P
Laboratory Science, Macha Research Trust, Choma, Zambia.
Simulundu E
Laboratory Science, Macha Research Trust, Choma, Zambia.
Chilumba I
Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.
Musukwa G
Laboratory Science, Macha Research Trust, Choma, Zambia.
Thuma P
Laboratory Science, Macha Research Trust, Choma, Zambia.
Kapungu K
Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.
Hamahuwa M
Laboratory Science, Macha Research Trust, Choma, Zambia.
Mutale I
Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.
Winter A
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Moss WJ
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. W Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Truelove SA
Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

MeSH

COVID-19COVID-19 VaccinesChildHumansMass VaccinationMeasles VaccinePandemicsSARS-CoV-2VaccinationVaccination HesitancyVaccinesZambia

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34227914

Citation

Carcelen, Andrea C., et al. "COVID-19 Vaccine Hesitancy in Zambia: a Glimpse at the Possible Challenges Ahead for COVID-19 Vaccination Rollout in sub-Saharan Africa." Human Vaccines & Immunotherapeutics, vol. 18, no. 1, 2022, pp. 1-6.
Carcelen AC, Prosperi C, Mutembo S, et al. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa. Hum Vaccin Immunother. 2022;18(1):1-6.
Carcelen, A. C., Prosperi, C., Mutembo, S., Chongwe, G., Mwansa, F. D., Ndubani, P., Simulundu, E., Chilumba, I., Musukwa, G., Thuma, P., Kapungu, K., Hamahuwa, M., Mutale, I., Winter, A., Moss, W. J., & Truelove, S. A. (2022). COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa. Human Vaccines & Immunotherapeutics, 18(1), 1-6. https://doi.org/10.1080/21645515.2021.1948784
Carcelen AC, et al. COVID-19 Vaccine Hesitancy in Zambia: a Glimpse at the Possible Challenges Ahead for COVID-19 Vaccination Rollout in sub-Saharan Africa. Hum Vaccin Immunother. 2022 12 31;18(1):1-6. PubMed PMID: 34227914.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa. AU - Carcelen,Andrea C, AU - Prosperi,Christine, AU - Mutembo,Simon, AU - Chongwe,Gershom, AU - Mwansa,Francis D, AU - Ndubani,Phillimon, AU - Simulundu,Edgar, AU - Chilumba,Innocent, AU - Musukwa,Gloria, AU - Thuma,Phil, AU - Kapungu,Kelvin, AU - Hamahuwa,Mutinta, AU - Mutale,Irene, AU - Winter,Amy, AU - Moss,William J, AU - Truelove,Shaun A, Y1 - 2021/07/06/ PY - 2021/7/7/pubmed PY - 2022/3/16/medline PY - 2021/7/6/entrez KW - COVID-19 KW - Zambia KW - vaccine KW - vaccine acceptance KW - vaccine hesitancy KW - vaccine safety SP - 1 EP - 6 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 18 IS - 1 N2 - With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/34227914/COVID_19_vaccine_hesitancy_in_Zambia:_a_glimpse_at_the_possible_challenges_ahead_for_COVID_19_vaccination_rollout_in_sub_Saharan_Africa_ L2 - https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1948784 DB - PRIME DP - Unbound Medicine ER -